With regard to pan-cancer analysis of alternative splicing, mutation of the splicing factor gene U2AF1 has been shown to result in both distinct and equal aberrant splicing events in lung adenocarcinoma and acute myeloid leukemia [37], indicating both specific and common regulation in the two cancer types. This evidence concerns the gene SLU7 and cancer.